Schwab M - Search Results

1

Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype *17.

Niemi M, Neuvonen PJ, Hofmann U, Backman JT, Schwab M, Lütjohann D, von Bergmann K, Eichelbaum M, Kivistö KT. Niemi M, et al. Among authors: schwab m. Pharmacogenet Genomics. 2005 May;15(5):303-9. doi: 10.1097/01213011-200505000-00005. Pharmacogenet Genomics. 2005. PMID: 15864131

2

Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism.

Lutz M, Schwab M, Griese EU, Marx C, Müller-Oerlinghausen B, Schönhöfer PS, Meisner C, Gleiter CH, Eichelbaum M, Mörike K. Lutz M, et al. Among authors: schwab m. Pharmacogenetics. 2002 Jan;12(1):73-5. doi: 10.1097/00008571-200201000-00010. Pharmacogenetics. 2002. PMID: 11773867

3

Discriminative quantification of cytochrome P4502D6 and 2D7/8 pseudogene expression by TaqMan real-time reverse transcriptase polymerase chain reaction.

Endrizzi K, Fischer J, Klein K, Schwab M, Nüssler A, Neuhaus P, Eichelbaum M, Zanger UM. Endrizzi K, et al. Among authors: schwab m. Anal Biochem. 2002 Jan 15;300(2):121-31. doi: 10.1006/abio.2001.5453. Anal Biochem. 2002. PMID: 11779102

4

Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency.

Haubitz M, Bohnenstengel F, Brunkhorst R, Schwab M, Hofmann U, Busse D. Haubitz M, et al. Among authors: schwab m. Kidney Int. 2002 Apr;61(4):1495-501. doi: 10.1046/j.1523-1755.2002.00279.x. Kidney Int. 2002. PMID: 11918757 Free article.

5

MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine.

Drescher S, Schaeffeler E, Hitzl M, Hofmann U, Schwab M, Brinkmann U, Eichelbaum M, Fromm MF. Drescher S, et al. Among authors: schwab m. Br J Clin Pharmacol. 2002 May;53(5):526-34. doi: 10.1046/j.1365-2125.2002.01591.x. Br J Clin Pharmacol. 2002. PMID: 11994059 Free PMC article. Clinical Trial.

6

Using trade names: a risk factor for accidental drug overdose.

Schwab M, Oetzel C, Mörike K, Jägle C, Gleiter CH, Eichelbaum M. Schwab M, et al. Arch Intern Med. 2002 May 13;162(9):1065-6. doi: 10.1001/archinte.162.9.1065. Arch Intern Med. 2002. PMID: 11996619

7

Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: consequences for enzyme expression and busulfan conjugation.

Bredschneider M, Klein K, Mürdter TE, Marx C, Eichelbaum M, Nüssler AK, Neuhaus P, Zanger UM, Schwab M. Bredschneider M, et al. Among authors: schwab m. Clin Pharmacol Ther. 2002 Jun;71(6):479-87. doi: 10.1067/mcp.2002.124518. Clin Pharmacol Ther. 2002. PMID: 12087351

8

Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.

Schwab M, Schäffeler E, Marx C, Fischer C, Lang T, Behrens C, Gregor M, Eichelbaum M, Zanger UM, Kaskas BA. Schwab M, et al. Pharmacogenetics. 2002 Aug;12(6):429-36. doi: 10.1097/00008571-200208000-00003. Pharmacogenetics. 2002. PMID: 12172211

9

Genetic polymorphisms of the human MDR1 drug transporter.

Schwab M, Eichelbaum M, Fromm MF. Schwab M, et al. Annu Rev Pharmacol Toxicol. 2003;43:285-307. doi: 10.1146/annurev.pharmtox.43.100901.140233. Epub 2002 Jan 10. Annu Rev Pharmacol Toxicol. 2003. PMID: 12359865 Review.

10

Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease.

Furuno T, Landi MT, Ceroni M, Caporaso N, Bernucci I, Nappi G, Martignoni E, Schaeffeler E, Eichelbaum M, Schwab M, Zanger UM. Furuno T, et al. Among authors: schwab m. Pharmacogenetics. 2002 Oct;12(7):529-34. doi: 10.1097/00008571-200210000-00004. Pharmacogenetics. 2002. PMID: 12360103

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,902 results

Search Page

Filters